Marimed (MRMD) Retained Earnings (2011 - 2026)

Marimed (MRMD) has 16 years of Retained Earnings data on file, last reported at $179.7 million in Q1 2026.

• On a quarterly basis, Retained Earnings rose 0.87% year-over-year to $179.7 million in Q1 2026; TTM through Mar 2026 was $179.7 million, a 0.87% increase from a year earlier, with the FY2025 full-year figure at -$127.9 million, down 173.79% from the prior year.
• Retained Earnings for Q1 2026 stood at $179.7 million, up from -$127.9 million in the prior quarter.
• Over the last five years, Retained Earnings for MRMD reached as high as $179.7 million in Q1 2026 and fell as low as -$127.9 million in Q4 2025.
• Historically, Retained Earnings has averaged $8.8 million across 5 years, with a median of -$88.7 million in 2022.
• Across the five-year window, Retained Earnings soared 283.46% in 2023 and sank 173.79% in 2025, its largest moves.
• Year by year, Retained Earnings stood at $142.4 million in 2022, then tumbled by 170.21% to -$100.0 million in 2023, then soared by 273.44% to $173.4 million in 2024, then slumped by 173.79% to -$127.9 million in 2025, then surged by 240.48% to $179.7 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $179.7 million in Q1 2026, -$127.9 million in Q4 2025, and $179.1 million in Q3 2025.